Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Distribution of CM500 in Healthy Volunteers and Patients With Cancer
NCT07781852Phase 1Not yet recruiting
- Sponsor
- Lumina Pharmaceuticals
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of CM500 in solid tumor (4 arms), sponsored by Lumina Pharmaceuticals. Primary endpoints: Pharmacokinetics at 48 hours, Standardized uptake value at 36 hours and 1 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
CM500
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07781852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07781852.